NDC 73141-025 – Maraviroc
Maraviroc 300 mg/1 · Tablet, Film Coated · Oral
Product NDC73141-025
Product details
- Brand name
- Maraviroc
- Generic name
- Maraviroc
- Labeler
- A2A Integrated Pharmaceuticals
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA217114
- Marketed since
- May 16, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- CCR5 Co-receptor Antagonist
Active ingredients
- Maraviroc 300 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 73141-025-02 | 60 TABLET, FILM COATED in 1 BOTTLE (73141-025-02) | May 16, 2024 |
Other Maraviroc products
- 50090-8005 Maraviroc 300 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-8010 Maraviroc 150 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 73141-024 Maraviroc 150 mg/1 · Tablet, Film Coated · A2A Integrated Pharmaceuticals
- 31722-579 Maraviroc 150 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-580 Maraviroc 300 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 72319-024 Maraviroc 150 mg/1 · Tablet, Film Coated · i3 Pharmaceuticals, LLC
- 72319-025 Maraviroc 300 mg/1 · Tablet, Film Coated · i3 Pharmaceuticals, LLC
- 68475-007 Maraviroc 300 mg/1 · Tablet, Film Coated · Navinta LLC
- 68475-008 Maraviroc 150 mg/1 · Tablet, Film Coated · Navinta LLC
- 72865-231 Maraviroc 150 mg/1 · Tablet, Film Coated · XLCare Pharmaceuticals Inc.
- 72865-232 Maraviroc 300 mg/1 · Tablet, Film Coated · XLCare Pharmaceuticals Inc.
- 70710-1930 Maraviroc 150 mg/1 · Tablet, Film Coated · Zydus Pharmaceuticals USA Inc.